0001013594-19-000540.txt : 20190925 0001013594-19-000540.hdr.sgml : 20190925 20190924180815 ACCESSION NUMBER: 0001013594-19-000540 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20190925 DATE AS OF CHANGE: 20190924 EFFECTIVENESS DATE: 20190925 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Confluent Biotech Capital Partners, LP CENTRAL INDEX KEY: 0001651358 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-247837 FILM NUMBER: 191111681 BUSINESS ADDRESS: STREET 1: 1290 TRAFALGAR STREET CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-357-4203 MAIL ADDRESS: STREET 1: 1290 TRAFALGAR STREET CITY: TEANECK STATE: NJ ZIP: 07666 D/A 1 primary_doc.xml X0708 D/A LIVE 0001651358 Confluent Biotech Capital Partners, LP 1290 TRAFALGAR STREET TEANECK NJ NEW JERSEY 07666 201-357-4203 DELAWARE None None Limited Partnership true Daniel Brothman 1290 Trafalgar Street Teaneck NJ NEW JERSEY 07666 Director Steven Furer 1290 Trafalgar Street Teaneck NJ NEW JERSEY 07666 Director Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.1 true 0001013594-18-000537 2014-01-01 true true true false 250000 Indefinite 1300000 Indefinite false 5 0 0 0 true The Investment Manager is entitled to receive an annual management fee of approximately 2% of the net asset value of each capital account. false Confluent Biotech Capital Partners, LP /s/ Daniel Brothman Daniel Brothman Managing Member of the General Partner 2019-09-24